French authorities placed three more regions under lockdown as the country tries to stop the spread of a growing outbreak.
Hospitals, prisons and nursing homes in Brisbane, Australia, went into lockdown on Friday after a 26-year-old man tested positive for the coronavirus, the first local transmission in the country in more than a week.
Kenya imposed stringent new restrictions on its capital, Nairobi, and in four other counties, after a 52 percent increase in hospital admissions this month.
A top health official in Germany warned that the country could have 100,000 new cases a day amid a new wave of the virus that he said was likely to be worse than either of the first two.
Get the latest updates here, as well as maps and vaccines in development.

The coming vaccine glut

By the end of July, the U.S. government will have had enough doses to vaccinate the country’s entire population, with 70 million doses to spare. Tens of millions more doses are promised to the U.S. in the months that follow.

With many poorer countries yet to receive a single dose, the Biden administration is coming under increasing pressure to figure out what to do with the excess stock, our colleagues Sharon LaFraniere and Noah Weiland report. It’s a question that will need to be answered within a matter of weeks, as the long manufacturing process will need to be adjusted if doses are to be sent abroad.

It’s not as simple as taking back surplus vaccines from states after they’ve inoculated their populations. Federal rules prohibit recalling them, and doses meant to be sent overseas would need to be relabeled and vials must be used within four to six months of being bottled.

Biden administration officials who would like to hold on to the surplus argue that children still need to be vaccinated, though clinical trial results from Moderna for children under age 12 are not expected until next fall. Immunity could also eventually wear off, which could require booster shots, but we don’t yet know when or whether that will happen.

With the deadline fast approaching, senior officials say the administration is nearing a decision. The government would keep the doses it has ordered, then later direct the extra shots to other nations in bilateral deals, or donate them to Covax, the international nonprofit that is trying to send doses to poorer nations.
The New York Times